Modification of the vestibular function with betahistine HCl.
D000328:Adult; D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors*; D001621:Betahistine / Q000494:pharmacology / Q000627:therapeutic use; D002199:Capillary Permeability / Q000187:drug effects; D002712:Chlorides / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D007758:Ear, Inner / Q000187:drug effects; D005021:Ethylamines / Q000494:pharmacology*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008575:Meniere Disease / Q000188:drug therapy*; D008875:Middle Aged; D010919:Placebos; D011725:Pyridines / Q000494:pharmacology*; D013268:Stimulation, Chemical; D014724:Vestibular Function Tests; D014722:Vestibule, Labyrinth / Q000187:drug effects*
D002712:Chlorides; D005021:Ethylamines; D010919:Placebos; D011725:Pyridines; D006631:Amine Oxidase (Copper-Containing); D001621:Betahistine